In line with the latter notion, low muscle NRK2 expression was associated with metabolite alterations in both skeletal muscle and serum of cancer patients, highlighting the future possibility to diagnose energy metabolism disturbances in CC patients with a simple venous blood sample. Here, NMRK2 is linked to cancer.